Crown Energy Ab · NGM:CRWN
Crown Energy Ab — AccYouRate — Investor Presentation (2023)
35 slides from Crown Energy Ab's investor presentation, 2023
Slide 1: General Presentation
ACCYOURATE AUGMENTED VITAL EXPERIENCE General Presentation
Slide 2: Agenda
1. Our Purpose 2. Our Technology 3. State of The Art 4. Our Plan 5. Company set-up 6. Value proposition & Next steps
Slide 3: Our Purpose
ACCYOURATE W wee, AUGMENTED VITAL EXPERIENCE OUR PURPOSE
Slide 4: Our Purpose: Increasing life expectancy, improving quality of life
OUR PURPOSE Increasing LIFE EXPECTANCY Improving QUALITY OF LIFE Raise health awareness and related choices 4
Slide 5: Our Ambition
OUR AMBITION Creating unseen MIXED BIO-VITAL KNOWLEDGE ECG. Breath. Posture… and turn it into HEALTHCARE BREAKTROUGH Continuous. Simple. Imperceptible. Reliable. New source of valuable health data 5
Slide 6: Our Technology
ACCYOURATE W wee, AUGMENTED VITAL EXPERIENCE OUR TECHNOLOGY
Slide 7: Our patented e-textile technology allows acquisition of bio-vital data
OUR PATENTED E-TEXTILE TECHNOLOGY ALLOWS THE ACQUISITION OF BIO-VITAL DATA THROUGH POLYMER SENSORS AND CONDUCTIVE TEXTILE CONNECTION AccYouRate proprietary and patented base polymer scheme Patented polymeric sensors capable of collecting bio-vital signals qualified as medical device (Certified as CE
Slide 8: Developed with top academic and technical centers, certified as medical device
IT HAS BEEN DEVELOPED IN COLLABORATION WITH TOP ACADEMIC AND TECHNICAL CENTERS AND IT IS NOW CERTIFIED AS MEDICAL DEVICE (Class II) University of L’Aquila University of Bologna Faculty of • Faculty of Medicine Telecommunication • Faculty of industrial Chemistry Engineering • Faculty of Physics • Fac
Slide 9: The polymer applied to our patented T-shirt
THE POLYMER HAS BEEN APPLIED TO OUR PATENTED T-SHIRT TO DELIVER THE HIGHEST COMFORT WHILE ENSURING A SEAMLESS DATA ACQUISITION DURING AN EXTENSIVE PERIOD OF USAGE FULLY SENSORS EMBEDDED WASHABLE IN FABRIC ORGANIC USER FRIENDLY AND SUITABLE FABRIC FOR DAILY USE “COTTON BASED” MEDICAL DEVICE CERTIFIED
Slide 10: A range of other sensorized products has been designed
A RANGE OF OTHER SENSORIZED PRODUCTS HAS BEEN DESIGNED, TO FURTHER ACCELERATE MARKET PENETRATION ACCYOURATE GROUP INNOVATIVE SENSORIZED PRODUCTS - OVERVIEW PRODUCTS YOUCARE YOUSAFE YOU USE YOU GO YOU WARD YOU YOU THINK BIOMARKER T-SHIRT FACE MASK GLOVE INSOLE TAPE RANGE HEAD BAND WRIST DURABLE / DUR
Slide 11: Technology recognized as breakthrough by external institutions
OUR TECHNOLOGY HAS BEEN RECOGNIZED AS BREAKTHROUGH BY A NUMBER OF EXTERNAL INSTITUTIONS 1. Awarded as “Leading e-textile innovation” by 4 different scientific boards, including the MIT’s Material Research Society in 2019 2. Awarded with 1 st prize for “Technology of the year” during Barcelon’s Mobil
Slide 12: Our T-shirt covers the key area of opportunity in the market
OUR T-SHIRT COVERS THE KEY AREA OF OPPORTUNITY TO WIN IN THE CURRENT MARKET, OPENING A NEW SEGMENT WITH RELEVANT GROWTH POTENTIAL High Mid COMFORT / WEARABILITY Low DATA RELIABILITY Low Mid High (non-medical) (Medical device) (Professional device) Leading the way into a fragemented scenario of unrel
Slide 13: T-shirt connected to a proprietary AI-driven cloud
THE T-SHIRT IS CONNECTED TO A PROPRIETARY AI-DRIVEN CLOUD CREATING A SYSTEM ABLE TO COLLECT, STORE AND ELABORATE A MASSIVE AMOUNT OF DATA T-shirt E-Textile Smart Tag Reliable Database Highly comfortable, cost efficient Acquisition through Bio-vital polymer World unique Cotton-2- AI-enabled elaborati
Slide 14: Levels of data elaborations
ENABLING A NEVER-SEEN LEVEL OF ELABORATION IN TERMS OF SCALE AND COMPLEXITY, DELIVERING HIGH-VALUE SERVICES TO MULTIPLE STAKEHOLDERS, FROM PUBLIC HEALTH SYSTEMS TO PRIVATE HEALTH-RELATED INSTITUTIONS Dynamic elaboration Actionable personalized Interactive community- Improved long-term $$$ LEVELS OF
Slide 15: Knowledge made available to end users through a simple app
THE KNOWLEDGE COMING FROM DATA ELABORATION WILL BE MADE AVAILABLE TO END USERS WITH OUR SIMPLE AND USER-FRIENDLY APP From raw data to user-friendly and sharable knowledge Including automatic alert systems to doctors and hospitals, in case of emergencies Opening a new era in the familiarity with one’
Slide 16: Delivering a true win-win-win system
ULTIMATELY DELIVERING A TRUE WIN-WIN-WIN SYSTEM Main target Individual Users Public and Private AccYouRate Stakeholders 1. Early prevention of real life- 1. Unique knowledge to drive Delivering on Company’s threatening risk relevant innovation Purpose : 2. Improvement of Life Quality 2. Savings/Cost
Slide 17: State of the Art
STATE OF THE ART
Slide 18: Market is ready and sizable, with wearables a strong growth opportunity
MARKET IS READY AND SIZABLE, WITH WEARABLES REPRESENTING A STRONG GROWTH OPPORTUNTIY, WITHIN THE ECG-MONITORING SEGMENT (others are equally important, e.g. sleep apneas, nearly 1 billion adults aged 30–69 years worldwide) ECG Monitoring Market ($B) Wearable ECG Monitor Market ($B) GLOBAL 14.2 8,3 2,
Slide 19: Potential market is huge as cardiovascular disease affects 130M people
THE POTENTIAL MARKET IS HUGE, AS CARDIOVASCULAR DISEASE AFFECT 130M PEOPLE GLOBALLLY, BUT A FAR LARGER NUMBER ARE AT RISK Million Individuals 2020 GLOBAL 1200 44% 530 25% 130 25% 30 60% 18 Hypertension CVD @ Risk CVD Diagnosed Heart Attacks/Strokes CVD Deaths Source: World Health Organization, The L
Slide 20: Opportunity to increase awareness of risk among those at risk
AMONG THOSE AT RISK, THERE IS AN OPPORTUNITY TO INCREASE THEIR AWARENESS OF THE RISK Million Individuals 2020 GLOBAL 1200 44% NOT AWARE/ NOT FULLY AWARE 530 25% 130 25% 30 60% 18 Hypertension CVD @ Risk CVD Diagnosed Heart Attacks/Strokes CVD Deaths Source: World Health Organization, The lancet, mar
Slide 21: Opportunity to reduce chances of a fatal event among those diagnosed
AMONG THOSE DIAGNOSED WITH CVD, THERE IS AN OPPORTUNITY TO REDUCE THE CHANCES OF A FATAL EVENT Million Individuals 2020 GLOBAL 1200 44% 530 FATAL EVENT REDUCTION 25% 130 25% 30 60% 18 Hypertension CVD @ Risk CVD Diagnosed Heart Attacks/Strokes CVD Deaths Source: World Health Organization, The lancet
Slide 22: By increasing the availability of cardiac programs
BY INCREASING THE AVAILAIBILITY OF CARDIAC PROGRAMS Heart Disease Conditions and Programs 2018 (M individuals) GLOBAL 20 18,3 1,7 Develop heart disease/year Served by current cardiac programs Patients in need gap Source: Science Daily 22
Slide 23: Several industries are striving for this kind of innovation
SEVERAL INDUSTRIES ARE STRIVING FOR THIS KIND OF INNOVATION INSURANCES BIG PHARMA PUBLIC HEALTH SYSTEMS Opportunity to upgrade the current BigPharma invest 20% of their Global Healthcare Spending is close to pricing model, to make it more revenues in R&D, equal to $120+B; $10 Trillion and grow
Slide 24: Several industries are striving for this kind of innovation
SEVERAL INDUSTRIES ARE STRIVING FOR THIS KIND OF INNOVATION TELEMEDICINE NGO’S DEFENSE/ MILITARY NGO’S doubled their H.C. budgets in Nato’s white book promote the use of Investments in TLM almost double in the past 14 months wearables as part of the new the last 2 yeas, from 8.3B to 14.6B; M
Slide 25: Health 2.0 services and investment booming trend
INCLUDING HEALTH 2.0 RELATED SERVICES, AS REPORTED BY LATEST INVESTMENT’S BOOMING TREND, FOLLOWING A BOOST OF NEW SERVICES APPROVED BY REGULATORS 25
Slide 26: AccYouRate system already proved successful in recent tests
ACCYOURATE SYSTEM ALREADY PROVED SUCCESSFUL IN RECENT TESTS Test with Italian Red Cross, Abruzzo’ Covid Commissioner and the Covid Hospital of Pescara : Jan-Jul 2021 Objectives Reduce hospitalization of COVID patients thanks to reliable and constant remote monitoring Verify seamless alert systems an
Slide 27: Plan signed with the Italian Red Cross, reaching 100K users by end 2023
PAVING THE WAY FOR THE IMPLEMENTATION OF PLAN SIGNED WITH THE ITALIAN REDCROSS, REACHING 100K USERS BY END 2023, SUFFICIENT TO ALREADY CREATE THE BIGGEST DATABASE IN THE WORLD! The REDCROSS agreement allows AccYouRate to build the first, biggest and most qualified cardio-vital data base ever made (#
Slide 28: Our Plan
OUR PLAN AUGMENTED VITAL EXPERIENCE. ACCYOURATE »
Slide 29: Launched with a B2B model, planning to move into B2C in 12-18 months
WE HAVE LAUNCHED WITH A ‘B2B’ MODEL, AND WE PLAN TO MOVE INTO THE COMPLEMENTARY ‘B2C’ MODEL IN THE NEXT 12-18 MONTHS PHASE #1 B2B Target Group #1 (Consumers Diagnosed SERVICE FEE INTERMEDIARY FREE AS BENEFIT/ WITH INCENTIVES with or at risk of Cardiovascular Disease) PHASE #2 B2C Target Group #2
Slide 30: 5 types of intermediaries identified for fastest market penetration
5 TYPES OF INTERMEDIARIES HAVE BEEN IDENTIFIED TO ENSURE THE FASTEST MARKET PENETRATION, BYPASSING THE FRAGMENTATION OF HEALTH SYSTEMS INSURANCES HEALTH-RELATED NGOS DEFENSE/ MILITARY TELEMEDICINE BIG PHARMA 30
Slide 31: Company Set Up
COMPANY SET UP accyourate Wy
Slide 32: Current Team
CURRENT TEAM Scientific Team Management team Investors and Advisors Prof. Violante - Chief Medical Officer Leading Mr. Arnaldo Usai – Founder and CEO, former Mr. Claudio Fabbri – Hedge Fund Founder and Occupational Medicine Scientist, President of President of Uniform Italia, a leading company in In
Slide 33: Value Proposition and Next Steps
VALUE PROPOSITION AND NEXT STEPS
Slide 34: AccYouRate plans for an ambitious growth
ACCYOURATE PLANS FOR AN AMBITIOUS GROWTH TODAY 12-18 MONTHS BY 2027-2028 TRULY WEARABLE TECHNOLOGY THAT BUILD THE LARGEST BIO-VITAL DATABASE HEALTHCARE BREAKTROUGH DELIVERS MEDICAL GRADE BIOVITAL DATA IN HISTORY Heavy tech R&D investments to retain leadership on Patented and award-winning technology
Slide 35: Thank You
THANK YOU FOR FUTHER INFO PLEASE CONTACT: E-mail: info@accyourate.com www.accyourate.com